$386M
$743,000
0.0% of portfolio
5,394
Q1 2025
Reduced 86.23%
$5.67B
$14,000
0.0% of portfolio
499
Q1 2025
Reduced 97.19%
$839M
$107,000
0.0% of portfolio
2,397
Q1 2025
Reduced 95.54%
$504M
$829,000
0.0% of portfolio
7,254
Q1 2025
Reduced 88.57%
$247M
$98,000
0.0% of portfolio
1,010
Q1 2025
Reduced 90.3%
$0
$276,000
0.0% of portfolio
7,480
Q1 2025
Reduced 96.31%
$19.1B
$654,000
0.0% of portfolio
24,139
Q1 2025
Reduced 97.29%
-
$131,000
0.0% of portfolio
-
Q1 2025
Reduced 95.21%
$4.97B
$742,000
0.0% of portfolio
87,348
Q1 2025
Reduced 99.15%
$3.11B
$801,000
0.0% of portfolio
58,609
Q1 2025
Reduced 98.63%
$981M
$417,000
0.0% of portfolio
3,595
Q1 2025
Reduced 88.4%
-
$54,000
0.0% of portfolio
-
Q1 2025
Reduced 91.86%
$4.35B
$321,000
0.0% of portfolio
12,195
Q1 2025
Reduced 97.37%
$750M
$255,000
0.0% of portfolio
6,729
Q1 2025
Reduced 96.21%
$2.47B
$49,000
0.0% of portfolio
742
Q1 2025
Reduced 93.4%
$2.11B
$616,000
0.0% of portfolio
72,725
Q1 2025
Reduced 99.15%
$924M
$188,000
0.0% of portfolio
6,599
Q1 2025
Reduced 97.15%
$17.8B
$183,000
0.0% of portfolio
829
Q1 2025
Reduced 77.93%
$334M
$188,000
0.0% of portfolio
5,418
Q1 2025
Reduced 96.53%
$3.55B
$20,000
0.0% of portfolio
19,217
Q1 2025
Reduced 99.9%
$51.2B
$701,000
0.0% of portfolio
692,469
Q1 2025
Reduced 99.9%
$415M
$255,000
0.0% of portfolio
15,428
Q1 2025
Reduced 98.35%
$290M
$88,000
0.0% of portfolio
380
Q1 2025
Reduced 76.84%
$671M
$109,000
0.0% of portfolio
6,035
Q1 2025
Reduced 98.19%
$440M
$671,000
0.0% of portfolio
5,663
Q1 2025
Reduced 88.15%
$1.39B
$759,000
0.0% of portfolio
38,876
Q1 2025
Reduced 98.05%
$188M
$151,000
0.0% of portfolio
3,641
Q1 2025
Reduced 95.85%
$372M
$298,000
0.0% of portfolio
4,038
Q1 2025
Reduced 92.62%
$128M
$126,000
0.0% of portfolio
1,202
Q1 2025
Reduced 89.52%
$1.37B
$354,000
0.0% of portfolio
19,466
Q1 2025
Reduced 98.18%
-
$26,000
0.0% of portfolio
-
Q1 2025
Reduced 98.31%
$5.93B
$237,000
0.0% of portfolio
90,522
Q1 2025
Reduced 99.74%
$602M
$312,000
0.0% of portfolio
5,856
Q1 2025
Reduced 94.67%
$4.35B
$88,000
0.0% of portfolio
6,919
Q1 2025
Reduced 98.73%
$9.6B
$25,000
0.0% of portfolio
6,846
Q1 2025
Reduced 99.63%
$10.4B
$60,000
0.0% of portfolio
11,131
Q1 2025
Reduced 99.46%
$24.3B
$396,000
0.0% of portfolio
13,729
Q1 2025
Reduced 97.12%
$473M
$72,000
0.0% of portfolio
2,882
Q1 2025
Reduced 97.5%
$4.94B
$415,000
0.0% of portfolio
17,679
Q1 2025
Reduced 97.65%
Guardian Pharmacy Svcs Inc Cl A
-
$38,000
0.0% of portfolio
-
Q1 2025
Reduced 95.3%
$3.45B
$104,000
0.0% of portfolio
19,151
Q1 2025
Reduced 99.46%
$4.24B
$832,000
0.0% of portfolio
32,515
Q1 2025
Reduced 97.44%
Gyre Therapeutics Inc Com
-
$236,000
0.0% of portfolio
-
Q1 2025
Reduced 87.05%
$3.26B
$179,000
0.0% of portfolio
16,967
Q1 2025
Reduced 98.95%
$810M
$393,000
0.0% of portfolio
11,483
Q1 2025
Reduced 96.58%
$3.21B
$278,000
0.0% of portfolio
17,667
Q1 2025
Reduced 98.43%
$0
$190,000
0.0% of portfolio
2,434
Q1 2025
Reduced 92.19%
$485M
$499,000
0.0% of portfolio
6,128
Q1 2025
Reduced 91.86%
$10.1B
$436,000
0.0% of portfolio
-
Q1 2025
Reduced 98.51%
$191M
$72,000
0.0% of portfolio
1,399
Q1 2025
Reduced 94.85%